The newly acquired ELITech Molecular Diagnostics business also contributed, positioning Bruker as an emerging infectious disease specialist in the in-vitro diagnostics (IVD) market. Within Bruker’s ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including ...

M&T Bank Corp lifted its stake in Bruker Co. (NASDAQ:BRKR – Free Report) by 303.1% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 17,870 shares of the medical ...

Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 ...

On Tuesday, 11 March 2025, Bruker Corporation (NASDAQ: BRKR) presented at the Barclays 27th Annual Global Healthcare Conference, outlining its strategic outlook amidst a mix of challenges and ...

Stock analysts at Zacks Research upped their Q4 2025 EPS estimates for Bruker in a research report issued to clients and investors on Thursday, March 6th. Zacks Research analyst R. Department now ...

Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences: ...

Good day, and welcome to the Bruker Corporation Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the ...

Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDON™, a high-performance 3D X-ray microscope (XRM) using micro-Computed Tomography (microCT). This innovative ...

Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock.

On Tuesday, 11 March 2025, Bruker Corporation (NASDAQ: BRKR) presented at the Barclays 27th Annual Global Healthcare Conference, outlining its strategic outlook amidst a mix of challenges and ...